This plan outlines the Agency’s strategic direction over the next five years, including how we ensure a smooth EU exit under any scenario.

 

Medicines and Healthcare Products Regulatory Agency: corporate plan, 2018 to 2023

Contents include the priority actions and activities which the Agency will take forward to ensure delivery of the statutory role and functions of the Agency.

Posted on the UK MHRA website on 24 April 2018